Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines
Authors:
Open Access
- 24 December 2022
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 198 (1) , 1-9
Abstract
Purpose: Breast cancer-related lymphedema (BCRL) represents a significant concern for patients following breast cancer treatment, and assessment for BCRL represents a key component of survivorship efforts. Growing data has demonstrated the benefits of early detection and treatment of BCRL. Traditional diagnostic modalities are less able to detect reversible subclinical BCRL while newer techniques such as bioimpedance spectroscopy (BIS) have shown the ability to detect subclinical BCRL, allowing for early intervention and low rates of chronic BCRL with level I evidence. We present updated clinical practice guidelines for BIS utilization to assess for BCRL. Methods and Results: Review of the literature identified a randomized controlled trial and other published data which form the basis for the recommendations made. The final results of the PREVENT trial, with 3-year follow-up, demonstrated an absolute reduction of 11.3% and relative reduction of 59% in chronic BCRL (through utilization of compression garment therapy) with BIS as compared to tape measurement. This is in keeping with real-world data demonstrating the effectiveness of BIS in a prospective surveillance model. For optimal outcomes patients should receive an initial pre-treatment measurement and subsequently be followed at a minimum quarterly for first 3 years then biannually for years 4–5, then annually as appropriate, consistent with previous guidelines; the target for intervention has been changed from a change in L-Dex of 10 to 6.5. The lack of pre-operative measure does not preclude inclusion in the prospective surveillance model of care. Conclusion: The updated clinical practice guidelines present a standardized approach for a prospective model of care using BIS for BCRL assessment and supported by evidence from a randomized controlled trial as well as real-world data.Keywords
This publication has 41 references indexed in Scilit:
- Breast Cancer–Related Lymphedema: Comparing Direct Costs of a Prospective Surveillance Model and a Traditional Model of CarePhysical Therapy, 2012
- Breast Cancer-Related Arm Lymphedema: Incidence Rates, Diagnostic Techniques, Optimal Management and Risk Reduction StrategiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Bioimpedance in the Assessment of Unilateral Lymphedema of a Limb: The Optimal FrequencyLymphatic Research and Biology, 2011
- Confirmation of the Reference Impedance Ratios Used for Assessment of Breast Cancer-Related Lymphedema by Bioelectrical Impedance SpectroscopyLymphatic Research and Biology, 2011
- Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trialBMJ, 2010
- Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up StudyJournal of Clinical Oncology, 2009
- Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatmentCA: A Cancer Journal for Clinicians, 2009
- Preoperative assessment enables the early diagnosis and successful treatment of lymphedemaCancer, 2008
- Bioelectrical Impedance Analysis: Proven Utility in Lymphedema Risk Assessment and Therapeutic MonitoringLymphatic Research and Biology, 2006
- MuIti‐frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post‐mastectomy patientsEuropean Journal of Clinical Investigation, 1992